Acrospire Investment Management LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 144 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2016$1,000
-98.5%
271
-97.7%
0.00%
-100.0%
Q3 2016$67,000
+17.5%
11,872
+13.4%
0.04%
+7.1%
Q2 2016$57,000
+3.6%
10,472
+42.1%
0.04%
+10.5%
Q1 2016$55,0007,3710.04%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2016
NameSharesValueWeighting ↓
Third Security, LLC 17,815,708$47,033,0002.93%
Essex Woodlands Management, Inc. 2,764,908$7,130,0002.60%
Belmont Global Advisors, Inc. 973,000$2,569,0002.01%
Belmont Global Advisors, Inc. 135,700$358,0000.28%
MSD Partners, L.P. 2,750,000$7,260,0000.22%
SFMG, LLC 99,850$264,0000.08%
Rotella Capital Management, Inc. 11,090$29,0000.03%
WESTPORT RESOURCES MANAGEMENT INC 33,500$88,0000.02%
SMITH ASSET MANAGEMENT GROUP LP 236,590$625,0000.02%
FRANKLIN STREET ADVISORS INC /NC 41,150$109,0000.02%
View complete list of ZIOPHARM ONCOLOGY INC shareholders